An international commission, including our Jeffrey Kahn, has been convened by the NAM, NAS, and the Royal Society with the participation of science & medical academies around the world, to develop a framework for scientists, clinicians, and regulatory authorities to consider when assessing potential clinical applications of human germline genome editing

Quick Read

Some U.S. researchers knew of a Chinese scientist’s intentions to implant edited embryos but were unable to stop him. Now scientific institutions are trying to devise global safeguards

Quick Read

Failure to vaccinate pregnant women during deadly infectious disease outbreaks is putting them and their unborn children at risk, a new report has warned

Quick Read

Inclusion of pregnant women in live vaccine trials is an ethical imperative

Quick Read

The Harvard Embryonic Stem Cell Research Oversight (the “ESCRO”) Committee, an ethics oversight committee charged with reviewing research protocols involving human embryos, human embryonic stem cells, and certain activities with non-embryonic human pluripotent stem cells, recently issued a report exploring the ethical issues related to the creation of synthetic human embryos

Quick Read

Revising the Genome

December 4, 2017

CRISPR lets scientists edit our genetic source code. This is going to be interesting. With comments from our Debra Mathews

Quick Read

Ethics guidance on priorities, inclusion, and evidence generation – enriched with additional links and resources, and broken into expandable sections for ease of reading and reference

Quick Read

The government doesn’t want to stand in the way of autonomous vehicles. That’s the biggest message to emerge from the Trump administration’s newly updated guidelines for the nascent robo-car industry.

Quick Read